UK Single-Use Bioreactors Market (2026-2031)
The UK Single-Use Bioreactors Market was valued at $273.2 Million in 2026 and projected to reach to $459.9 Million by 2031, representing a compound annual growth rate of 11.0%. The UK single-use bioreactors market is positioned for sustained growth through 2031, supported by the region's leading pharmaceutical and biotechnology sector.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK Single-Use Bioreactors Market Trends and Insights
- The UK market benefits from strong pharmaceutical and biotechnology infrastructure, with increasing adoption of single-use technologies driven by regulatory support and cost efficiency demands.
- UK manufacturers and contract development and manufacturing organizations (CDMOs) are increasingly transitioning to single-use systems to reduce capital expenditure and improve operational flexibility. Driving the UK market expansion is the region's commitment to biopharmaceutical innovation and the growing prevalence of personalized medicine initiatives.
- The UK's position as a leading European biotech hub, combined with government investment in life sciences, supports accelerated deployment of single-use bioreactor platforms.
- Between 2026 and 2031, the UK market will experience sustained growth as companies prioritize scalability, reduced contamination risk, and faster time-to-market for therapeutic products. The UK market reflects broader European trends while maintaining distinct regulatory pathways and competitive dynamics.
- UK-based organizations are leveraging single-use bioreactor technology to enhance manufacturing resilience and meet evolving patient demand for advanced therapies..
Key Market Statistics
- CAGR (2026-2031) 11.0% CAGR
- Market Size, 2026 ~USD 273.2 Million
- Forecast, 2031 ~USD 459.9 Million
- Country UK
UK Single-Use Bioreactors Market Overview
Market Valuation :
The UK single-use bioreactors market is valued at $273.2 million in 2026 and is projected to reach $459.9 million by 2031, demonstrating robust growth potential in the region.
Strong Growth Trajectory :
With an 11% CAGR through 2031, the UK market is outpacing many European counterparts, driven by increasing adoption of single-use technologies among UK pharmaceutical and biotech companies.
Regulatory Support & Infrastructure :
The UK benefits from a well-established regulatory framework and world-class pharmaceutical infrastructure, facilitating faster adoption of single-use bioreactor technologies and supporting innovation.
Cost Efficiency & Scalability :
UK manufacturers and contract development organizations are increasingly leveraging single-use bioreactors to reduce operational costs, minimize contamination risks, and accelerate time-to-market for biologics.
UK Single-Use Bioreactors Market Dynamics
- Increasing demand for personalized medicine, cell and gene therapies, and vaccine production is driving adoption of single-use technologies among UK-based manufacturers and CDMOs.
- Regulatory bodies continue to support innovation, while cost pressures and sustainability concerns favor single-use over traditional stainless steel systems. Key growth drivers include expansion of UK biotech clusters, rising investment in advanced manufacturing capabilities, and growing partnerships between UK companies and global biopharmaceutical firms.
- The market will benefit from technological advancements in bioreactor design, improved scalability, and enhanced monitoring capabilities, positioning the UK as a competitive hub for single-use bioreactor adoption and manufacturing..
Market Ecosystem
SINGLE-USE BIOREACTORS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Deployed six 4,000 L ABEC CSR single-use bioreactors at its Pune facility to support large-scale manufacturing of Novavax’s NVX-CoV2373 vaccine. | Established 24,000 L of single-use production capacity | The 4,000 L systems doubled productivity per unit of floor space, supported accelerated facility startup, and reduced manufacturing cost per dose. |
 |
Implemented Cytiva Xcellerex Disposable Reactors (XDR) for mAb and bispecific antibody production. | Demonstrated that XDR bioreactors can be used effectively for antibody production | The system met all benchmarks for viable cell density, viability, integral viable cell count (IVC), and titer | The real-time CO2 monitoring proved effective, allowing maintenance of optimal culture conditions. |
 |
Implemented Sartorius Ambr and BIOSTAT STR platforms, ranging from process-development systems to 500 L and 2,000 L single-use bioreactors, at its San Diego biologics facility. | Enabled consistent scale-up from development to GMP production, improved process-data continuity, and supported seamless technology transfer for Phase I through commercial biologics manufacturing. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- The UK single-use bioreactors market is valued at $273.2 million in 2026 and will reach $459.9 million by 2031, growing at 11.0% CAGR.
- The UK's strong biotech ecosystem and government life sciences investment are primary drivers of single-use bioreactor adoption.
- UK CDMOs and manufacturers are prioritizing single-use systems to reduce costs, improve flexibility, and accelerate time-to-market.
- The UK market will benefit from increased demand for personalized medicine and advanced therapeutic manufacturing between 2026 and 2031.
Single-Use Bioreactors Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CELL & GENE THERAPY (Molecule Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12% from 2026 to 2031 |
| Largest Segment | BIOPRODUCTION (Application) |
| Market Size Base Year (Billions) | ~USD 5.44 (2026) |
| Revenue Forecast (Billions) | ~USD 9.58 (2031) |
| Segments Covered | Product, Scale Range, Type, Molecule Type, Cell Type, Application, Process Mode, End User |
UK Single-Use Bioreactors Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product
- Other Products
- Single-Use Assemblies
- Single-Use Bags
- Single-Use Bioreactor Systems
By Scale Range
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- <=10 L Bioreactors
By Type
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 2D Single-Use Bags
- 3D Single-Use Bags
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- Bubble-Column Single-Use Bioreactors
- Fixed-Bed Single-Use Bioreactors
- Other Single-Use Bioreactors
- Stirred-Tank Single-Use Bioreactors
- Wave-Induced Single-Use Bioreactors
- <=10 L Bioreactors
By Molecule Type
- Cell & Gene Therapy
- Monoclonal Antibodies
- Therapeutic Proteins & Peptides
- Vaccines
By Cell Type
- Bacterial Cells
- Mammalian Cells
- Other Cells
- Yeast Cells
By Application
- Bioproduction
- Process Development
- Research & Development
By Process Mode
- Batch Process Mode
- Feb-Batch Process Mode
- Fed-Batch Process Mode
- Perfusion/Continuous Process Mode
By End User
- Academic & Research Institutes
- Cros & Cmos
- Pharmaceutical & Biotechnology Companies
Target Audience
- UK Pharmaceutical Manufacturers : Need market intelligence to evaluate single-use bioreactor adoption, benchmark against competitors, and optimize manufacturing strategies for cost efficiency and regulatory compliance.
- Contract Development & Manufacturing Organizations (CDMOs) : Require detailed market data to assess demand for single-use bioreactor services, identify growth opportunities, and plan capacity investments to serve UK and European clients.
- Bioreactor Equipment Suppliers : Need UK market insights to develop targeted sales strategies, understand customer requirements, and identify expansion opportunities within the region's growing biotech sector.
- Biotech & Cell Therapy Companies : Seek market analysis to evaluate single-use bioreactor solutions for manufacturing scale-up, assess supplier options, and understand cost-benefit dynamics specific to UK operations.
- Investment & Strategy Consultants : Require comprehensive UK market data to advise clients on market entry, M&A opportunities, and strategic positioning within the single-use bioreactor ecosystem.
Reasons to Buy this Report
- UK-Specific Market Sizing : Obtain precise valuation data for the UK market ($273.2M in 2026) with detailed forecasts through 2031, enabling accurate budgeting and investment planning for UK operations.
- Competitive Landscape Analysis : Understand UK-based manufacturers, CDMOs, and key players driving market growth, including their market share, capabilities, and strategic positioning within the region.
- Regulatory & Infrastructure Insights : Gain detailed knowledge of UK regulatory environment, compliance requirements, and manufacturing infrastructure supporting single-use bioreactor adoption and deployment.
- Growth Driver Identification : Identify UK-specific growth catalysts including biotech cluster expansion, investment trends, and sector-specific demand from cell therapy, vaccine, and biologics manufacturers.
- Strategic Decision Support : Make informed decisions on market entry, partnerships, and expansion strategies in the UK with comprehensive data on market dynamics, customer needs, and emerging opportunities.
Frequently asked questions
What is the current size of the UK single-use bioreactors market?
The UK single-use bioreactors market is valued at $273.2 million in 2026.
What is the projected market size for the UK by 2031?
The UK single-use bioreactors market is forecast to reach $459.9 million by 2031.
What is the growth rate of the UK single-use bioreactors market?
The UK market is expected to grow at an 11.0% compound annual growth rate (CAGR) from 2026 to 2031.
Why is the UK adopting single-use bioreactor technology?
UK manufacturers and CDMOs are adopting single-use bioreactors to reduce capital expenditure, minimize contamination risk, improve operational flexibility, and accelerate time-to-market for therapeutic products.
What factors are driving growth in the UK single-use bioreactors market?
Key drivers include the UK's strong biotech infrastructure, government investment in life sciences, increasing demand for personalized medicine, and the need for scalable, cost-efficient manufacturing solutions.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include National Institutes of Health (NIH), National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), Biotechnology Innovation Organization (BIO), BioProcess International, BioPharm International, BioPlan Associates, Organisation for Economic Co-operation and Development (OECD) R&D Expenditure, National Center for Biotechnology Information (NCBI), World Health Organization (WHO), Food and Drug Administration (FDA); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Single-use bioreactors (SUBs) or disposable bioreactors consist of a disposable bag instead of a typical stainless steel or glass culture vessel. SUBs are based on single-use technology, which uses disposable components to manufacture biopharmaceutical products. The key benefits of single-use bioreactors include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater manufacturing flexibility. These advantages make single-use systems particularly attractive for producing biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.
The report presents the market size for single-use bioreactor systems, single-use bags, single-use assemblies, and other products that can be incorporated with single-use bioreactors.
Key Stakeholders
- Manufacturers of single-use bioreactors and associated products
- Distributors of single-use bioreactors and related products
- Pharmaceutical and biotechnology companies
- Contract manufacturing companies (CMOs)
- Contract research organizations (CROs)
- Academic and research institutes
- Life sciences companies
- Market research and consulting firms
- Venture capitalists and investors
- Government organizations
- Medical institutes and universities
- Private research firms
Report Objectives
- To define, describe, and forecast the global single-use bioreactors market based on product, type, cell type, process mode, molecule type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall single-use bioreactors market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the single-use bioreactors market
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the single-use bioreactors market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe single-use bioreactors market, by country
- A further breakdown of the Rest of Asia Pacific single-use bioreactors market, by country
- A further breakdown of the Rest of Latin America single-use bioreactors market, by country
Get the Full Single-Use Bioreactors Market Report
Full forecast, segment splits, and company analysis for all Single-Use Bioreactors Market.
- Canada Single-Use Bioreactors Market
- US Single-Use Bioreactors Market
- Germany Single-Use Bioreactors Market
- France Single-Use Bioreactors Market
- Italy Single-Use Bioreactors Market
- Spain Single-Use Bioreactors Market
- China Single-Use Bioreactors Market
- South Korea Single-Use Bioreactors Market
- Japan Single-Use Bioreactors Market
- India Single-Use Bioreactors Market
- Australia Single-Use Bioreactors Market
- Brazil Single-Use Bioreactors Market
- Mexico Single-Use Bioreactors Market
- Rest Of Europe Single-Use Bioreactors Market
- Rest Of Asia Pacific Single-Use Bioreactors Market
- Rest Of Latin America Single-Use Bioreactors Market
- Rest Of GCC Countries Single-Use Bioreactors Market
- Saudi Arabia (Ksa) Single-Use Bioreactors Market
- United Arab Emirates (UAE) Single-Use Bioreactors Market
- GCC Countries Single-Use Bioreactors Market
- Rest Of Middle East Single-Use Bioreactors Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
